AnaptysBio Inc. (NASDAQ: ANAB) announced its board of directors authorized a $100 million stock repurchase program and provided updates on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE